Home › Funds › UBS Group AG › ALGS
UBS Group AG position in ALGS
ALIGOS THERAPEUTICS INC · Health Care
Latest position (Q2 2026)59.99K sh
Reported value held$346.12K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 728 | $11.00K | New |
| Q4 2021 | 7.56K | $90.00K | Add |
| Q1 2023 | 2.33K | $2.04K | New |
| Q2 2023 | 113 | $110 | Reduce |
| Q3 2023 | 5.43K | $4.06K | Add |
| Q1 2024 | 10.82K | $10.61K | New |
| Q2 2024 | 362 | $127 | Reduce |
| Q3 2024 | 14 | $121 | Reduce |
| Q4 2024 | 15.52K | $618.36K | Add |
| Q1 2025 | 8.46K | $69.80K | Reduce |
| Q2 2025 | 2.74K | $19.78K | Reduce |
| Q3 2025 | 16.18K | $158.58K | Add |
| Q4 2025 | 364 | $3.39K | Reduce |
| Q1 2026 | 37.06K | $275.36K | Add |
| Q2 2026 | 59.99K | $346.12K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ALGS
- Vanguard Group 200.40K sh · $1.87M · Q4 2025
- Marshall Wace 246.58K sh · $1.42M · Q2 2026
- Hillhouse Capital (HHLR Advisors) 76.25K sh · $439.94K · Q2 2026
- D. E. Shaw & Co 66.46K sh · $383.49K · Q2 2026
- Geode Capital Management 47.17K sh · $272.32K · Q2 2026
- BlackRock Inc 30.29K sh · $174.78K · Q2 2026
- Renaissance Technologies 10.80K sh · $62.32K · Q2 2026
- Citigroup Inc 1.81K sh · $10.43K · Q2 2026
- JPMorgan Chase & Co 344 sh · $1.87K · Q2 2026
- Morgan Stanley 204 sh · $1.18K · Q2 2026
- Wells Fargo & Co 100 sh · $577 · Q2 2026